Delivery Order SPE2DB20D2014-SPE2DB25FD04D
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for Rocuronium 50 mg/5 ml vials with a ceiling value of $1,126.08. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Rocuronium 100 mg/10 mL vials. This is a firm fixed-price delivery order with a ceiling value of $1,105.56 and an ultimate completion date of June 17, 2025. The contract represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 14, 2025, and performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 ml vials totaling $1,166.98 under firm fixed pricing. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,346.81. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,255.90 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rocuronium 50 mg/5 ml vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 19, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on September 3, 2025. This non-set-aside, competitively awarded contract carries a ceiling value of $1,166.98 under a firm fixed-price arrangement, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,105.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rocuronium 100 mg/10 mL vials. This competitively awarded, non-set-aside contract carries a ceiling value of $1,105.56 and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD04DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,902.07. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The Rocuronium order supports Department of Defense medical operations by providing this neuromuscular blocking agent, a critical pharmaceutical used in anesthesia and medical procedures across military healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/18/25 |